MEDISTEP — Medistep Healthcare Income Statement
0.000.00%
- IN₹583.30m
- IN₹576.55m
- IN₹496.55m
- 34
- 40
- 54
- 37
Annual income statement for Medistep Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 76.2 | 276 | 391 | 497 |
Cost of Revenue | ||||
Gross Profit | 5.74 | 15.2 | 48.8 | 61 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 73.3 | 264 | 345 | 441 |
Operating Profit | 2.96 | 12.7 | 45.3 | 55.7 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 2.54 | 12.3 | 44.5 | 55.4 |
Provision for Income Taxes | ||||
Net Income After Taxes | 1.9 | 9.21 | 33.3 | 41.4 |
Net Income Before Extraordinary Items | ||||
Net Income | 1.9 | 9.21 | 33.3 | 41.4 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 1.9 | 9.21 | 33.3 | 41.4 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.134 | 0.601 | 2.34 | 2.92 |